Neuro-Oncology Reviews
Volume
28 Number 9
31 March 2026
Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 9, 31 March
Forbes GE, Avery RA.
Pediatric Optic
Pathway Gliomas: Diagnosis, Management, and Outcomes.
Int
Ophthalmol Clin. 2026 Mar 23;66(2):126-139. doi:
10.1097/IIO.0000000000000611. PMID:
41870103. ˍ
Lasica AB, Tang AR, Iqbal A, Nakhate V, Wen PY.
Recent
Advances in Targeted Therapies for Adult Gliomas.
Curr
Neurol Neurosci Rep. 2026 Mar 24;26(1):20. doi:
10.1007/s11910-026-01484-4. PMID:
41874881. ˍ
Cassim S, Montemagno C.
Neural
Innervation of Tumors: Mechanisms, Hallmarks, and Therapeutic
Opportunities.
Cancers
(Basel). 2026 Mar 25;18(7):1063. doi:
10.3390/cancers18071063. PMID:
41976286. ˍ
Moon R, Mueller S, Varlet P.
Intrinsic
pontine tumors: Pathology of brainstem tumors and exploration of
diffuse intrinsic pontine glioma.
Handb
Clin Neurol. 2026 Mar 25;216:171-182. doi:
10.1016/B978-0-443-15736-3.00020-2. PMID:
41896005. Review˰ ˍ
Pinkham MB, Sim HW, Jeffree RL, Lasocki A, Legge DM, Saran F,
Satgunaseelan L, Gan HK.
Management of
Adult Patients With Isocitrate Dehydrogenase-Mutant Gliomas in
Australia: An Expert Position Statement From the Cooperative
Trials Group for Neuro-Oncology.
Asia
Pac J Clin Oncol. 2026 Mar 25;22(3):392-403. doi:
10.1111/ajco.70070. PMID:
41881841. ˍ
Chi E, Chillakuru R, Ganti L.
Stereotactic
Radiosurgery in the Treatment of Craniofacial and Brain Tumors: A
Bibliometric Analysis.
J
Craniofac Surg. 2026 Mar 26. doi:
10.1097/SCS.0000000000012667. PMID:
41885619. ˍ
Pernia Marin M, Almabrok H, Miller ML, Haggiagi A.
The
Elusive Origin of Glioblastoma: Where Do We Stand?
Cells.
2026 Mar 26;15(7):590. doi:
10.3390/cells15070590. PMID:
41972682. ˍ
Guo S, Zhao W, Liu J, Wang N, Ji P, Wang L, Wang Y.
Mapping
the global research landscape and innovations on elderly glioma: a
bibliometric analysis.
Front
Oncol. 2026 Mar 27;16:1769459. doi:
10.3389/fonc.2026.1769459. PMID:
41971454. ˍ
Ramsoomair CK, Daftari M, Benchouia R, Estevez-Ordonez D, Aka A,
Himic V, Aramburu-Berckemeyer M, Kreatsoulas D, Govindarajan V,
Chandar JS, Ivan ME, Komotar RJ, Shah A.
Locoregional
delivery of CAR T cells in high-grade gliomas: a systematic
analysis of safety, efficacy, and emerging biomarkers of response.
J
Immunother Cancer. 2026 Mar 27;14(3):e014450. doi:
10.1136/jitc-2025-014450. PMID:
41895715. ˍ
Al Salmi HZ, Al-Saadi HR, Al Maskari AY, Al Maskari SY, Al-Saadi
TD.
Bridging surgery and radiotherapy:
the role of stereotactic radiosurgery in pediatric brain tumor
care.
Childs
Nerv Syst. 2026 Mar 28;42(1):139. doi:
10.1007/s00381-026-07223-x. PMID:
41904275˰ ˍ
Shallak M, Shaik AKB, Gatta A, Volpi M, Accolla RS, Forlani G.
New
concepts for glioblastoma vaccine immunotherapy.
Biomed
J. 2026 Mar 28:100974. doi:
10.1016/j.bj.2026.100974. PMID:
41912068. ˍ
Moeini Y, Bakhshi A, Ghoflchi S, Taghavi A, Hosseini H, Jalili-Nik
M.
Curcumin Analogs in Glioblastoma
Therapy: A Narrative Review.
Curr
Med Chem. 2026 Mar 30. doi:
10.2174/0109298673428440260303054650. PMID:
41918192˰ ˍ
Esparragosa Vázquez I, Fortes de la Torre I, Hilario A,
Iglesias Lozano I, Hernández-Laín A, Pineda E,
Sepúlveda Sánchez JM, Vaz-Salgado MA.
Multidisciplinary consensus
recommendations for the management of IDH-mutant grade 2 gliomas
in Spain: a Delphi study.
Clin
Transl Oncol. 2026 Mar 31. doi:
10.1007/s12094-026-04338-0. PMID: 41915118. ˍ